Industry Research Reports: Pharmaceutical

Showing posts with label Pharmaceutical. Show all posts

Thursday 22 August 2013

New Study: Supplement Market Share in the US 2012-2016

TechNavio's analysts forecast the Supplement market in the US to grow at a CAGR of 4.65 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the aging population. The Supplement market in the US has also been witnessing the increasing use of weight-loss supplements. However, lack of product innovation could pose a challenge to the growth of this market.

To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/supplement-market-in-the-us-2012-2016

TechNavio's report, the Supplement Market in the US 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Supplement market in the US landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space include Abbott Laboratories Inc., GNC Holdings Inc., NBTY Inc., Otsuka Holdings Co. Ltd., and Perrigo Co.

The other vendors mentioned in the report are Arizona Nutritional Supplements Inc., Atrium Innovations Inc., BASF SE, Bayer Healthcare AG, Bio-Engineered Supplements and Nutrition Inc., CytoSport Inc., Delavau LLC, Glanbia plc, Herbalife International, International Vitamin Corp., Iovate Health Sciences Inc., Metagenics Inc., Nestlé S.A., Nordic Naturals Inc., Pfizer Inc., Schiff Nutrition Group Inc., and VitaQuest International LLC.

Key questions answered in this report:

What will the market size be in 2016 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?

1. Executive Summary

2. List of Abbreviations

3. Introduction

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/173015

4. Market Research Methodology

Market Research Process

Research Design

Research Methodology

5. Scope of the Report

Market Overview

Product Offerings

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog: http://industry-research-reports.blogspot.com/

Monday 19 August 2013

Research Report: Global Industry Psychotherapeutic Drugs Market Growth 2013 - 2019

Psychotherapeutic drugs market is comprised of drugs which are used to treat mental illnesses such as confused thinking, extreme mood swings, long lasting depression, social withdrawal and suicidal thought. Commonly found mental disorders are schizophrenia, bipolar disorder, anxiety and depression. Schizophrenia is a mental disease associated with hearing voices, unorganized speech and broken thoughts. Depression is a common disorder characterized by lack of confidence, pleasure and interest.

To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/psychotherapeutic-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

The global Psychotherapeutic Drugs Market is segmented on the basis of various therapeutic classes used to treat mental illness such as antipsychotics (chlorpromazine, haloperidol), antidepressants (amitriptyline, clomipramine), antimaniacs (lithium, carbamazepine) and anxiety drugs (lorazepam, alprazolam). Antipsychotic is one of the fastest growing segments owing to increasing incidences of mental disorders such as schizophrenia and bipolar disorder. Atypical antipsychotics are the most preferred antipsychotics because they are more efficacious than first generation antipsychotics. Top selling antipsychotic drugs are Abilify, Seroquel, Risperdal and Zyprexa.

The global psychotherapeutic drugs market is growing worldwide due to high prevalence of emotional and mental diseases. According to WHO report approximately 350 million people are suffering from depression and around 24 million people are affected by schizophrenia around the world as of today. Patent expiration of top psychotic drugs Prozac, Geodon and Zyprexia has opened way for generic manufacturers and it is expected that in coming years generic segment will rise dramatically and will give rise price competition in the psychotherapeutic drugs market.

America has been the largest market accounting for more than 40% of the total psychotherapeutic drugs market owing to high incidences of schizophrenia and depression among baby boomers. It is predicted that the market will witness rapid growth in Asia-Pacific under the influence of changing life style, disease awareness and growing aging population.

The key players operating in this market are Eli Lilly, Bristol-Meyer Squibb, GlaxoSmithKline, Pfizer, Astrazeneca, Astellas Pharma Inc., Wyeth and Johnson & Johnson.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America
Asia Pacific
Europe
Rest of the World

This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

To Buy The Copy of This Report Visit : http://www.marketresearchreports.biz/analysis/172827

Reasons for Buying this Report

This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog: http://industry-research-reports.blogspot.com/

Wednesday 7 August 2013

Deep Research Report: Global Industry Micronutrients Market Trends 2013 - 2019

Description

The human body needs nutrients in small quantities which are very necessary for proper physiological functioning and growth. These nutrients are known as micronutrients. Humans and other living organisms require these micronutrients throughout their life span. Micronutrients are also essential elements for growth of the plants and their productivity. Due to extensive cropping the amount of micronutrients present in soil is drastically decreased. Intensive use of chemicals and fertilizers results in less productive soil. To fulfill basic need of micronutrients to substantial level crops and plans are provided with some amount of micronutrients according to their need.

To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/micronutrients-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

By end users, fruits, vegetable crops and cereals are the major areas of agricultural sector having demand for micronutrients. Agricultural micronutrients find applications in fertigation, foliar and soil etc. Soil application is most dominating one in global market. Micronutrients can be applied in chelated form or non-chelated. Non-chelated form is in demand with largest global share. Zinc was overall dominating micronutrient. Some other micronutrients are boron, manganese, molybdenum, copper, iron, cobalt, nickel and chlorine. Asia-Pacific is the largest market for agricultural micronutrients followed by North America, Europe and RoW. North America is still expected to grow in this market, although at a lower growth rate than the rest of the regions.

One of the major driving factors for this market is increasing deficiency of micronutrients in soil. Industrialization is demanding more and more land resulting in shortage of land for agriculture; hence need for more productivity. Increase in population leads to demand for more cereals. Use of micronutrients in antiretroviral therapy for HIV positive people is one of the future trends.

Agro-K Corporation, BASF SE, Agrium Inc. Aries Agro Limited, Cheminova A/S, Bms Micro-Nutrients N.V. Baicor L.C. Atp Nutrition, Deepak Fertilisers And Petrochemicals Corporation Ltd, Coromandel International Ltd, Gujarat State Fertilizers & Chemicals Ltd. and Micnelf Usa Inc. are some of the key players in this market.

To Buy The Copy of This Report Visit : http://www.marketresearchreports.biz/analysis/172432

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

USA – Canada Toll Free: 866-997-4948

Email: sales@marketresearchreports.biz

Website: http://www.marketresearchreports.biz/

Blog: http://industry-research-reports.blogspot.com/

Recent Release: Printed Electronics for Healthcare, Cosmetics and Pharmaceuticals Market Size 2014-2024

Description

Printed electronics for healthcare and beauty encompasses stretchable, flexible, conformal and sometimes biodegradable electronics and electrics. It is very thin and lightweight, even in hybrid constructions that, for now, incorporate conventional integrated circuits (IC), light emitting diodes (LED) and other chips in a partly printed device in order to perform functions not yet possible with entirely printed surfaces. Saving up to 40% of cost, space and weight and making new things possible are typical achievements. This is the only up to date, comprehensive report on this rapidly emerging technology and covers; electronic medical implants, patches, disposables, and drug and cosmetic dispensing: stretchable, flexible, wide area, low cost, disposable electronics. It looks at how technologies such as NFC are impacting healthcare provision.

To Read the Complete Report with TOC Visit:http://www.marketresearchreports.biz/analysis-details/printed-electronics-for-healthcare-cosmetics-and-pharmaceuticals-2014-2024

New Enabling Technology - but what are the real opportunities vs hype?

Printed and potentially printed thin film electronics provides many benefits in healthcare and beauty including low cost in many cases, even to the point of disposability, and greatly enhanced functionality in other cases. Frequently, it makes new things possible. It does this in two ways. It is the basis of totally new components relying on new physical principles, examples including metamaterials and memristors. Secondly it makes possible the creation of new devices such as self-powered implants that never need a battery to be replaced. Battery replacement by surgical procedure causes up to 3% of fatalities.

All this addresses the modern needs of healthcare in the private house and on-the-go and more effective, affordable healthcare and beauty products that are easier to use, unobtrusive, greener, automatic and safer. The greying of the population and lack of staff and facilities for conventional healthcare are addressed.

This new technology takes an increasing variety of forms from implants to smart skin patches, radio frequency identification (RFID) and smart packaging. The human interface is improved with sound, moving images, light emitting graphics and so on. Other functions achieved are as widely different as automatic drug delivery and anticounterfeiting. Multiple benefits are commonplace. In a drug trial, recording which pill was removed, when, and plotting this helps patients to do better - get well sooner - and reduces the amount of corrupt data.